Monoclonal antibodies directed against cancer antigen 19–9 (CA19-9) or carcino-embryonic antigen (CEA) were conjugated to a green fluorophore and delivered intravenously into nude mice with orthotopic human pancreatic or colon tumors [5]. The gene discussed is CEACAM5; the disease is colonic neoplasm.